Vimovo FDA Approved Drugs
NAPROXEN AND ESOMEPRAZOLE MAGNESIUM [Esomeprazole Magnesium2C17H18N3O3SMg3H2O : NaproxenC14H14O3]
RX
- eq 20mg base : 375mg (oral tablet, delayed release)
eq 20mg base : 500mg (oral tablet, delayed release)
Dr Reddys Labs LtdSep 27, 2013
VIMOVO [Esomeprazole Magnesium2C17H18N3O3SMg3H2O : NaproxenC14H14O3]
RX
- eq 20mg base : 375mg (oral tablet, delayed release)
eq 20mg base : 500mg (oral tablet, delayed release)
Horizon Pharma UsaApr 30, 2010
- Relief of signs and symptoms of arthritis and risk-reduction of nsaid-associated gastric ulcer.
- Risk-reduction of nsaid gastric ulcer in patients requiring chronic nsaid treatment.
- Risk-reduction of nsaid-associated gastric ulcer in patients requiring nsaid treatment.
- Risk-reduction of nsaid-associated gastric ulcer.
- Risk-reduction of nsaid-associated gastric ulcers in patients also taking low dose aspirin.
WARNING: Consult a licensed physician in the appropriate field for medical treatment and drug prescription. Do not self medicate.